- Home
- OSUR vs HYI Comparison
OSUR vs HYI Comparison
Compare OSUR & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- HYI
- Stock Information
- Founded
- OSUR 2000
- HYI 2010
- Country
- OSUR United States
- HYI United States
- Employees
- OSUR N/A
- HYI N/A
- Industry
- OSUR Medical/Dental Instruments
- HYI Investment Managers
- Sector
- OSUR Health Care
- HYI Finance
- Exchange
- OSUR Nasdaq
- HYI Nasdaq
- Market Cap
- OSUR 289.4M
- HYI 279.2M
- IPO Year
- OSUR 1986
- HYI N/A
- Fundamental
- Price
- OSUR $3.87
- HYI $12.16
- Analyst Decision
- OSUR Buy
- HYI
- Analyst Count
- OSUR 3
- HYI 0
- Target Price
- OSUR $6.67
- HYI N/A
- AVG Volume (30 Days)
- OSUR 771.3K
- HYI 50.6K
- Earning Date
- OSUR 11-06-2024
- HYI 01-01-0001
- Dividend Yield
- OSUR N/A
- HYI 9.59%
- EPS Growth
- OSUR N/A
- HYI N/A
- EPS
- OSUR 0.15
- HYI N/A
- Revenue
- OSUR $224,263,000.00
- HYI N/A
- Revenue This Year
- OSUR N/A
- HYI N/A
- Revenue Next Year
- OSUR N/A
- HYI N/A
- P/E Ratio
- OSUR $25.02
- HYI N/A
- Revenue Growth
- OSUR N/A
- HYI N/A
- 52 Week Low
- OSUR $3.72
- HYI $10.99
- 52 Week High
- OSUR $8.45
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- OSUR 44.24
- HYI 52.28
- Support Level
- OSUR $3.80
- HYI $11.87
- Resistance Level
- OSUR $4.01
- HYI $12.21
- Average True Range (ATR)
- OSUR 0.14
- HYI 0.14
- MACD
- OSUR -0.00
- HYI 0.01
- Stochastic Oscillator
- OSUR 41.67
- HYI 82.86
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.